Why allopurinol is given in cyanide poisoning
allopurinol cyanide poisoning mechanism xanthine oxidase
allopurinol cyanide poisoning xanthine oxidase free radicals reperfusion
Hypoxanthine + O₂ --[Xanthine Oxidase]--> Xanthine + Superoxide (O₂•-)
Xanthine + O₂ --[Xanthine Oxidase]--> Uric Acid + Superoxide (O₂•-)
| Aspect | Detail |
|---|---|
| Primary mechanism of cyanide toxicity | Inhibits cytochrome A3 → blocks electron transport → no ATP |
| Why allopurinol is used | Blocks XO → prevents reperfusion-phase superoxide burst |
| Classification in cyanide Rx | Adjunct / cytoprotective agent, NOT primary antidote |
| Primary antidotes | Hydroxocobalamin (first-line), or sodium nitrite + sodium thiosulfate |
| XO inhibition benefit | Reduces ROS-mediated secondary organ damage after cyanide is cleared |
Why allopurinol is given in carbon monoxide poisioninh
| Mechanism | Effect |
|---|---|
| Binds hemoglobin → CO-Hb | Reduced O₂ carrying capacity + left shift of O₂ dissociation curve |
| Binds cytochrome A3 | Blocks electron transport chain → same as cyanide poisoning |
| Binds myoglobin | Direct skeletal and cardiac muscle damage |
| Activates guanylyl cyclase in CNS | ↑cGMP → cerebral vasodilation → loss of consciousness |
| Induces nitric oxide (NO) synthesis | ↓ systemic BP; triggers xanthine oxidase pathway |
CO exposure
↓
↑ Nitric Oxide (NO) synthesis
↓
NO enhances neutrophil adhesion to endothelium
(via β-integrin adherence molecules)
↓
Neutrophil activation → activates Xanthine Oxidase (XO)
↓
XO catalyzes: Hypoxanthine + O₂ → Xanthine + O₂•⁻ (superoxide)
Xanthine + O₂ → Uric acid + O₂•⁻ (superoxide)
↓
Free radicals oxidize brain lipids (lipid peroxidation)
↓
DELAYED NEUROLOGICAL SEQUELAE (DNS)
| Feature | Cyanide Poisoning | CO Poisoning |
|---|---|---|
| Primary insult | Cytochrome A3 blockade | CO-Hb + cytochrome A3 blockade |
| Free radical trigger | Ischemia-reperfusion on treatment | NO-induced XO activation during/after exposure |
| XO activation pathway | ATP → hypoxanthine accumulation during ischemia | NO → neutrophil β-integrin → XO activation |
| Main target of allopurinol | Reperfusion injury | Delayed neurological sequelae (DNS) |
| Primary antidotes | Hydroxocobalamin; nitrite + thiosulfate | 100% O₂ / hyperbaric O₂ |
| Allopurinol role | Adjunct - cytoprotective | Adjunct - neuroprotective |